Publications

Potent In Vivo Anti-HIV-1 Activity of the Nonimmunosuppressive Cyclosporin UNIL-025

UNIL-025, a Novel Potent HIV-1 Inhibitor

Cyclosporine A prodrug for topical delivery to the eye

The sustained release of the acetylcholinesterase inhibitor ZT-1 confers the potential for a more efficient neuroprotection in rats

Phase IIa Clinical Study of a New Human Neutrophil Elastase Inhibitor, EPI-hNE4 (DX890), with repeated Administration by Inhalation in Adult…

H3 Pharma receives Orphan-drug designation from the FDA for: monoclonal antibody SC-1, in gastric cancer

Comparative Efficacy of Triptorelin Pamoate and Leuprolide Acetate in Men with Advanced Prostate Cancer

Ki16425, a Subtype-Selective Antagonist for EDG-Family Lysophosphatidic Acid Receptors

Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer